CD40 Engagement on Endothelial Cells Promotes Tissue Factor-dependent Procoagulant Activity

Summary

The CD40 molecule expressed on endothelial cells has been shown to transduce activation signals resulting in upregulation of adhesion molecules. Herein, we studied the impact of CD40 engagement on the induction of tissue factor (TF)-dependent procoagulant activity (PCA) at the surface of human umbilical vein endothelial cells (HUVECs). First, we found that co-incubation of HUVECs with 3T6 fibroblasts transfected with the CD40L gene (3T6-CD40L) resulted in a clear induction of PCA which was not observed with control untransfected fibroblasts. The specificity of this finding was established by inhibition experiments using monoclonal antibodies (mAbs) blocking CD40 or CD40L. PCA induced by CD40 ligation was TF-related as it was not observed in factor VII-deficient plasma and was associated with the accumulation of TF mRNA. To investigate the role of CD40/CD40L interactions in the induction of endothelial cell PCA by lymphocytes, interferon (IFN)-γ-stimulated EC were incubated with T cells in the absence or presence of anti-CD40 or anti-CD40L mAb. The 60-70% inhibition of PCA induced by these mAbs but not their isotype-matched control indicated that the CD40 pathway is involved in the induction of PCA resulting from interactions between activated HUVECs and T cells. We conclude that activation signals elicited by CD40 engagement on endothelial cells result in the induction of TF-dependent PCA. The CD40/CD40L pathway might therefore be involved in the development of prothrombic states during diseases associated with endothelial cell and T cell activation.

• References

• 1 Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
• 2 Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MAJ. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 4533-7.
• 3 Nawroth PP, Stern DM. Endothelial cell procoagulant properties and the host response. Semin Thromb Hemost 1987; 13: 391-7.
• 4 Grabowski EF, Lam FP. Endothelial cell function, including tissue factor expression, under flow conditions. Thromb Haemost 1995; 74: 123-8.
• 5 Furie B, Furie BC. P-selectin induction of tissue factor biosynthesis and expression. Haemostasis 1996; 26 (Suppl. 01) 60-5.
• 6 Schmid E, Muller TH, Budzinski RM, Pfizenmaier K, Binder K. Lymphocyte adhesion to human endothelial cells induces tissue factor expression via a juxtacrine pathway. Thromb Haemost 1995; 73: 421-8.
• 7 Schmid E, Muller TH, Budzinski RM, Binder K, Pfizenmaier K. Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J Interferon Cytokine Res 1995; 15: 819-25.
• 8 Alderson MR, Armitage RJ, Tough TW, Strockbine L, Fanslow WC, Spriggs MK. CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40. J Exp Med 1993; 178: 669-74.
• 9 Wagner Jr DH, Stout RD, Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte inter-leukin-1 synthesis. Eur J Immunol 1994; 24: 3148-54.
• 10 Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med 1994; 180: 1263-72.
• 11 Hollenbaugh D, Mischel Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA, Aruffo A. Expression of functional CD40 by vascular endothelial cells. J Exp Med 1995; 182: 33-40.
• 12 Karmann K, Hughes CC, Schechner J, Fanslow WC, Pober JS. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995; 92: 4342-6.
• 13 Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D, Chess L. Functional interactions of T cells with endothelial cells: the role of CD40LCD40-mediated signals. J Exp Med 1995; 182: 1857-64.
• 14 Pradier O, Marchant A, Abramowicz D, De Pauw L, Vereestraeten P, Kinnaert P, Vanherweghem JL, Capel P, Goldman M. Procoagulant effect of the OKT3 monoclonal antibody: Involvement of tumor necrosis factor. Kidney Int 1992; 42: 1124-9.
• 15 Pradier O, Willems F, Abramowicz D, Schandene L, de Boer M, Thielemans K, Capel P, Goldman M. CD40 engagement induces monocyte procoagulant activity through an interleukin-10 resistant pathway. Eur J Immunol 1996; 26: 3048-54.
• 16 Hasselaar P, Derksen RHWM, Oosting JD, Blokzijl L, de Groot PG. Synergistic effect of Low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells. Thromb Haemost 1989; 62: 654-60.
• 17 Pradier O, Surquin M, Stordeur P, DePauw L, Kinnaert P, Vereerstraeten P, Capel P, Goldman M, Abramowicz D. Monocyte procoagulant activity induced by in vivo administration of the OKT3 monoclonal antibody. Blood 1996; 87: 3768-74.
• 18 Helin H, Edgington TS. Allogeneic induction of the human T cell-instructed monocyte procoagulant response is rapid and is elicited by HLA-DR. J exp Med 1983; 158: 962.
• 19 Snapper CM, Zelazowski P, Rosas FR, Kehry MR, Tian M, Baltimore D, Sha WC. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J Immunol 1996; 156: 183-91.
• 20 Parry GC, Mackman N. A set of inducible genes expressed by activated human monocytic and endothelial cells contain kappa B-like sites that specifically bind c-Rel-p65 heterodimers. J Biol Chem 1994; 269: 20823-5.
• 21 Hancock WW, Gee D, De Moerloose P, Rickles FR, Ewan VA, Atkins RC. Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation 1985; 39: 430-8.
• 22 Blakely ML, Van der Werf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059-66.
• 23 Carlsen E, Gaudernack G, Filion-Myklebust C, Pettersen KS, Prydz H. Allogeneic induction of the thromboplastin synthesis in monocytes and endothelial cells. Biphasic effect of cyclosporin A. Clin Exp Immunol 1989; 76: 428-33.
• 24 Jaiswal AI, Dubey C, Swain SL, Croft M. Regulation of CD40 ligand expression on naive T cells: a role for TCR but not co-stimulatory signals. Int Immunol 1996; 8: 275-85.
• 25 Mach F, Schonbeck U, Sukhova GK, Bourcier T, Bonnefoy JY, Pober JS, Libby P. Funtional CD40 ligand is expressed on human vascular endothelial cells smooth muscle cells, and macrophages: Implication for CD40-CD40 ligand signalling in the atherosclerosis. Proc Natl Sci USA 1997; 94: 1931-6.
• 26 Laman JD, Smet B de JGL, Schoneveld A, van Meurs M. CD40-CD40L interaction in atherosclerosis. Immunol Today 1997; 18: 272-7.